ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1339	National Cancer Institute	Html	en	"Light" Cigarettes and Cancer Risk	This fact sheet answers questions about the health effects of smoking	tar yield ratings 0.57737 Tobacco Control Act 0.536069 [PubMed Abstract] 0.48947 lung cancer 0.486686 cigarette engineering 0.5215 cancer prevention study 0.484602 full-flavor cigarettes 0.614325 tobacco 0.630562 tobacco manufacturers 0.618735 Tobacco Control Monograph 0.517669 light cigarette 0.806133 tar 0.70637 color-coded packaging 0.502935 tobacco industry 0.590796 silver packaging 0.501078 tobacco products 0.527514 Family Smoking Prevention 0.526471 President Barack Obama 0.486716 cigarette package design 0.557863 Smoking Cigarettes 0.586945 previously marketed products 0.585107 full-flavor cigarette 0.528959 so-called light cigarette 0.757572 regular cigarettes 0.701052	acute myeloid leukemia 0.482821 safe cigarette 0.580948 National Cancer Institute 0.624018 smoking machine 0.528809 greater tar exposure 0.608329 machine-measured tar yields 0.568171 light cigarettes 0.927757 lower yield 0.510032 Cigarette features 0.526777 frequent puffs 0.539497 USA. Tobacco Control 0.516673 Cigarette tar yields 0.63309 Federal Trade Commission 0.480817 tobacco product 0.533894 Tobacco Control 0.618394 health 0.488561 Low Machine-Measured Yields 0.486658 regular cigarette 0.682678 Certain redesigned cigarettes 0.623296 Chronic Disease Prevention 0.481608 ultralight cigarettes 0.61529 extra cigarettes 0.558295 tobacco industry documents 0.585198 cigarette design 0.541406	CLICK HERE
1413	National Cancer Institute	Html	en	Delirium (PDQ®)–Patient Version	Expert-reviewed information summary about delirium as a complication of cancer or its treatment. Supportive care and pharmacologic approaches to the management of delirium are discussed.	delirium symptoms 0.709857 nitrogen waste products 0.577723 PDQ cancer information 0.770129 health care team 0.586883 clinical trial search 0.576381 white blood cells 0.577889 clinical trials 0.698332 health care providers 0.640731 cancer information summary 0.69366 health care professionals 0.630449 clinical trial 0.629959 family members 0.626279 breast cancer prevention 0.590247 risk factors 0.581853 PDQ summaries 0.586791 patients 0.70258 cancer patients 0.599627 latest published information 0.583983 NCI’s PDQ 0.59158 NCI PDQ cancer 0.638613 medical conditions 0.583938 mental state 0.591128 treatment 0.629672 medicines 0.581999	cancer prevention 0.590786 Cancer Information Service 0.600573 PDQ Supportive 0.581242 patient 0.833691 treatment clinical trials 0.58693 National Cancer Institute 0.701492 PDQ documents 0.58189 delirium 0.950204 health care 0.718989 Palliative Care Editorial 0.637171 new treatment 0.588734 Cancer Care page 0.597168 PDQ database 0.584618 patient changes 0.579334 Care Editorial Board 0.639637 risk factor 0.616509 PDQ summary 0.609325 cancer clinical trials 0.602276 cancer information summaries 0.605913 health professional versions 0.578381 comprehensive cancer information 0.605614 cancer patient 0.595386 Older patients 0.584199 cancer 0.788674	CLICK HERE
1449	National Cancer Institute	Html	en	Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.	imatinib arm. 0.510874 imatinib treatment 0.498472 BCR/ABL tyrosine kinase. 0.475402 chronic phase 0.568994 selective imatinib intensification 0.531551 chronic-phase CML 0.475324 Kantarjian HM 0.499766 standard-dose imatinib therapy 0.507991 myeloid leukemia patients 0.529265 optimized high-dose imatinib 0.503652 imatinib dose escalation 0.504714 chronic myeloid leukemia 0.974854 myelogenous leukemia patients 0.471866 first-line imatinib 0.514414 newly diagnosed patients 0.526185 CML 0.506893 patients 0.710768 imatinib 0.732822 chronic myelogenous leukemia 0.688539 molecular response 0.621232 blast crisis 0.504661 complete cytogenetic response 0.48751 high-dose imatinib 0.517116 previous tyrosine kinase 0.510969 complete cytogenetic responses 0.473533	tyrosine kinase inhibitor 0.619296 BCR/ABL tyrosine kinase 0.479945 et al. 0.49902 Treatment-Naïve Chronic Myeloid 0.474051 Imatinib plasma trough 0.531841 tyrosine kinase 0.812535 imatinib group 0.503477 allogeneic bone marrow 0.520192 newer tyrosine kinase 0.511438 imatinib mesylate 0.627198 Dasatinib Versus Imatinib 0.532218 more-potent tyrosine kinase 0.486098 bone marrow transplantation 0.522565 tyrosine kinase inhibitors 0.801096 10-year follow-up period 0.488853 front-line imatinib 0.512448 daily imatinib mesylate 0.512872 major molecular response 0.597118 Abstract 0.523832 Clin Oncol 0.565656 imatinib mesylate treatment 0.521115 bone marrow 0.522631 chronic myeloid leukaemia 0.4741 imatinib era 0.488593	CLICK HERE
1796	National Cancer Institute	Html	es	Depresión (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del diagnóstico, evaluación y tratamiento de la depresión en adultos y niños que padecen de cáncer.	PDQ Adaptación 0.900589 pequeño número 0.729693 querido enfermo 0.783448 siguientes aspectos 0.842073 Physician Data Query 0.803023 antidepresivos quizás 0.773298 salud mental 0.794578 suficiente apoyo 0.736237 siguientes razones 0.808967 sustancias químicas ayuda 0.796554 Anfotericina B 0.785281 médico hará preguntas 0.761623	único irdn 0.752807 Red Nacional 0.736951 niños quizás 0.74099 efectos tardíos 0.735838 busque ayuda 0.740646 National Cancer Institute 0.721502 siguientes riesgos 0.72378 siguientes pruebas 0.814768 PDQ Depresión 0.788745 siguientes temas 0.821536 Instituto Nacional 0.830302	CLICK HERE
1867	National Cancer Institute	Html	es	Tratamiento del cáncer de seno paranasal y de cavidad nasal (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno paranasal y de cavidad nasal.	Lippincott Williams 0.142692 Wynstra JH 0.159843 Sterman BM 0.185832 Neck Cancer Cooperative 0.146574 Pilepich MV 0.159353 Solero CL 0.185478 seno etmoides 0.29943 necesarias radioterapia 0.151326 Pfister DG 0.146109 malignant tumors 0.232702 paranasal sinus 0.195953 Arch Otolaryngol Head 0.468056 Radiat Oncol Biol 0.619431 DeVita VT Jr 0.178945 Anterior craniofacial resection 0.258045 Shah JP 0.184681 Levine HL 0.185883 Rosenberg SA 0.139862 placas pterigoides 0.137887 radiation therapy 0.436289 Head Neck Surg 0.553355 Factors influencing 0.192749 Neck Tumors 0.161157 Lawrence TS 0.140398 Mendenhall WM 0.145915	Head Neck 0.837692 nasal vestibule 0.268686 radioterapia postoperatoria 0.19834 paranasal sinus tumors 0.157406 radioterapia posoperatoria 0.262078 Otolaryngol Head Neck 0.541214 craniofacial resection 0.26625 Mariani L 0.182178 Cantù G 0.181147 PDQ Tratamiento 0.251079 Hawkins RB 0.160122 9th ed 0.144765 Kraus DH 0.187503 nasal cavity 0.24641 Werning JW 0.146295 Oncol Biol Phys 0.641171 cánceres nasofaríngeos 0.195804 skull base 0.209046 sección cáncer 0.172955 Acta Otorhinolaryngol Belg 0.258981 neck cancer 0.879092 Acta Oncol 0.146983 adjuvant radiotherapy 0.160643 haz externo 0.195232	CLICK HERE
1942	National Cancer Institute	Html	es	Tratamiento de las neoplasias mielodisplásicas o mieloproliferativas (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de las neoplasias mielodisplásicas o mieloproliferativas, incluso las leucemias mielomonocítica crónica o juvenil y la LMC atípica.	French-American-British Cooperative Leukaemia 0.312371 leucemia mieloide 0.341853 myelomonocytic leukaemia 0.397359 myelomonocytic leukemia with 0.326213 platelet-derived growth factor 0.354049 with juvenile chronic 0.315892 Arber DA 0.312178 health organization classification 0.3281 Leukemia Group 0.315441 genes platelet-derived growth 0.312347 with juvenile 0.340061 chronic myeloid leukemia 0.336615 myelomonocytic leukemia 0.944712 leucemia mielomonocítica 0.387953 chronic myelomonocytic leukemia 0.819447 differentiating myelomonocytic leukemia 0.320578 Beran M 0.312167 World Health Organization 0.355665 neoplasias mielodisplásicas 0.314258 stem cell transplantation 0.313202 chronic myelogenous leukemia 0.364294 Germing U 0.362762 myeloproliferative disorders 0.313394 cases with chronic 0.311538 Leuk Lymphoma 0.332534	myelomonocytic leukemia from 0.33992 chronic myelomonocytic leukaemia 0.386185 juvenile chronic myelogenous 0.347073 marrow transplantation 0.341155 Organización Mundial 0.317633 chronic myeloid 0.357031 Differentiating juvenile myelomonocytic 0.319715 myeloid neoplasms 0.336696 bone marrow transplantation 0.325127 Bennett JM 0.319603 cromosoma filadelfia 0.337822 recuento plaquetario 0.325577 juvenile myelomonocytic leukaemia 0.339361 juvenile myelomonocytic leukemia 0.545157 chronic myeloid leukaemias 0.320258 Clin Oncol 0.32115 Orazi A 0.343564 Cooperative Leukaemia Group 0.311788 atypical chronic 0.319445 características clínicas 0.316309 trastornos mieloides 0.311632 leucemia mieloide aguda 0.316238 with chronic myelomonocytic 0.340508 Emanuel PD 0.350668	CLICK HERE
2004	National Cancer Institute	Html	es	Familiares a cargo de pacientes de cáncer (PDQ®)–Versión para pacientes	Sumario informativo revisado por expertos acerca de los desafíos que enfrentan los familiares a cargo de los pacientes con cáncer. Este resumen se centra en las funciones típicas y las inquietudes de las personas a cargo del paciente y en las intervenciones útiles para esas personas.	etapa final 0.997354 medicamento ayuda 0.410369 antecedentes médicos 0.415405 duro trabajo 0.413212 siguientes aspectos 0.407494 siguientes tareas 0.552864 PDQ Familiares 0.404616 siguientes estrategias 0.423753 largo plazo 0.416925 orientación ayuda 0.4088 siguientes riesgos 0.402546 paciente ayuda 0.564496 comunicación ayuda 0.423969 Instituto Nacional 0.414173 habilidades específicas mejora 0.409415	paciente colabora 0.698305 bienestar espiritual ayuda 0.42734 Physician Data Query 0.413876 siguientes recompensas 0.416674 menudo personas 0.450696 Medical Leave Act 0.420162 escaso apoyo 0.411288 Caregiver Cancer Education 0.408929 numerosas tareas 0.412096 PDQ Comunicación 0.408163 terminales ayuda 0.406412 largo tiempo 0.456845 importantes decisiones 0.42081 viejos problemas 0.406452	CLICK HERE
2064	National Cancer Institute	Html	es	Exposición al asbesto y el riesgo de cáncer	Hoja informativa sobre el asbesto, sobre las enfermedades relacionadas con el asbesto e incluye organizaciones para obtener más información.	técnicos profesionales automotrices 0.5421 gen bap1 0.530949 que familiares de trabajadores 0.533144 normas descritas 0.532666 largo plazo 0.526581 Protección Ambiental 0.672505 World Trade Center 0.546459 principal dependencia 0.532045 Ground Zero 0.529197 derrames pleurales benignos 0.558277 Salud Ocupacional 0.584399 asbesto crisótilo 0.987156 trabajadores portuarios 0.606054 Instituto Nacional 0.563708 menores riesgos 0.533274 Trabajo de EE 0.535904 Employment Standards Administration 0.548898 titulado current best practices 0.543841 Mine Safety 0.535362 sustancias tóxicas 0.635631 siglo xix 0.53032 distintos tipos 0.525229 Estados Unidos 0.992615 automotriz usa 0.531695 Public Affairs 0.529764	serios problemas 0.529441 Environmental Protection Agency 0.815767 línea telefónica tsca 0.556811 Preventing Asbestos Exposure 0.544747 Product Safety Commission 0.67091 Information Division 0.52746 Occupational Safety 0.586355 asbesto causa 0.952053 cuánto tiempo 0.527545 en la mucosidad 0.531534 a las personas 0.529484 posibles peligros 0.5266 Health Administration 0.652906 Consumer Product Safety 0.672282 causa dificultad 0.530297 sumamente bajo. Los fabricantes 0.528798 mejores prácticas 0.574094 Clutch Repair Workers 0.544379 Veterans Affairs 0.528386 Torres Gemelas 0.52642 Compensation Programs 0.5287 Disease Registry 0.526245 Toxic Substances 0.526971 Segunda Guerra Mundial 0.550565	CLICK HERE
3457	National Cancer Institute	Html	es	Aromaterapia y aceites esenciales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del uso de la aromaterapia y los aceites esenciales para mejorar la calidad de vida de los pacientes de cáncer.	Aromaterapia Holística 0.562365 células madre 0.538543 Centro Nacional 0.523442 cuidado médico 0.513326 New Hampshire Avenue 0.516719 Edad Media 0.513057 Drug Administration 0.51036 materiales básicos 0.513447 NCI Best Case 0.529134 Asociación Nacional 0.510623 International Aromatherapists 0.5134 datos bibliográficos pubmed 0.517834 efectos calmantes 0.525108 índices respiratorios 0.51441 Canadian Federation 0.513125 National Cancer Institute 0.519273 aromaterapia mejora 0.571233 siguientes riesgos 0.511793 frecuencia respiratoria 0.513664 Instituto Nacional 0.589131 acupuntura ayuda 0.509756 antigua china 0.513893	Salud Complementaria 0.537165 Visuals Online 0.511883 complementarias revisa 0.516354 Federación Canadiense 0.511817 Physician Data Query 0.568256 sistema nervioso central 0.524289 verdaderos aceites 0.552975 bacterias mrsa 0.514519 Estados Unidos 0.774616 francés rene gattefosse 0.524782 libre uso 0.513229 National Association 0.51158 PDQ Aromaterapia 0.574967 página manejo 0.510182 ¿El tratamiento 0.520191 International Federation 0.512341 ¿Los beneficios 0.51034 juntos cam 0.50992 Holistic Aromatherapy 0.51402 Series Program 0.51015 medicina complementaria 0.964619	CLICK HERE
3603	National Cancer Institute	Html	en	The Biology of Cancer Health Disparities	Melanie Nix is a triple-negative breast cancer survivor.	colorectal cancer driver 0.435767 therapeutic drug development 0.379727 higher prostate cancer 0.449833 tumor suppressor 0.38934 tumor suppressor protein 0.381004 non-Ashkenazi Jewish women 0.407407 health statistics data 0.392619 poor prognosis 0.391856 early-stage colorectal cancer 0.438229 health disparities 0.477585 white men 0.458069 ethnic groups 0.593764 higher death rate 0.400926 5-year relative survival 0.383397 E-cadherin-mediated cell–cell adhesion 0.379902 prostate cancer cells 0.46714 triple-negative breast cancer 0.489042 Colorectal cancer incidence 0.443522 colorectal cancer 0.538585 health care services 0.381316 prostate cancer risk 0.477396 BRCA1 gene mutation 0.382642 biological factors 0.392157 tyrosine kinase activity 0.387964 colorectal cancers 0.435353	cancer health disparities 0.462858 poor prognosis subtype 0.390421 rare genetic variant 0.379533 tyrosine kinase 0.398457 African Americans 0.45451 triple-negative disease 0.382957 triple-negative breast cancers 0.481447 poorer breast cancer 0.423969 percent 0.4497 African American men 0.969659 African American patients 0.426534 ephrin type-A receptor 0.387324 premenopausal women 0.412405 prognosis molecular subtype 0.394461 germline BRCA1 mutations 0.399431 African American women 0.819019 breast cancer 0.507647 prostate cancer growth 0.440137 prostate cancer diagnosis 0.440132 prostate cancer 0.701352 non-Hispanic white women 0.414153 aggressive prostate cancer 0.430828 receptor tyrosine kinase 0.392354 higher nuclear levels 0.389163	CLICK HERE